nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—CYP2E1—Sulfadiazine—malaria	0.112	0.178	CbGbCtD
Mitoxantrone—CYP2E1—Proguanil—malaria	0.0895	0.142	CbGbCtD
Mitoxantrone—CYP3A4—Clindamycin—malaria	0.0591	0.0939	CbGbCtD
Mitoxantrone—CYP2E1—Quinine—malaria	0.0577	0.0917	CbGbCtD
Mitoxantrone—CYP2E1—Quinidine—malaria	0.0507	0.0806	CbGbCtD
Mitoxantrone—CYP2E1—Dapsone—malaria	0.0437	0.0695	CbGbCtD
Mitoxantrone—CYP3A4—Sulfadiazine—malaria	0.0339	0.0539	CbGbCtD
Mitoxantrone—ABCB1—Quinine—malaria	0.0292	0.0464	CbGbCtD
Mitoxantrone—CYP3A4—Artemether—malaria	0.0289	0.0459	CbGbCtD
Mitoxantrone—CYP3A4—Proguanil—malaria	0.0271	0.0431	CbGbCtD
Mitoxantrone—CYP3A4—Doxycycline—malaria	0.0257	0.0409	CbGbCtD
Mitoxantrone—ABCB1—Quinidine—malaria	0.0256	0.0408	CbGbCtD
Mitoxantrone—CYP3A4—Quinine—malaria	0.0175	0.0278	CbGbCtD
Mitoxantrone—CYP3A4—Quinidine—malaria	0.0154	0.0244	CbGbCtD
Mitoxantrone—PIM1—IL5-mediated signaling events—CISH—malaria	0.0143	0.18	CbGpPWpGaD
Mitoxantrone—CYP3A4—Dapsone—malaria	0.0132	0.0211	CbGbCtD
Mitoxantrone—PIM1—IL3-mediated signaling events—CISH—malaria	0.00844	0.107	CbGpPWpGaD
Mitoxantrone—BTK—blood plasma—malaria	0.00811	0.0901	CbGeAlD
Mitoxantrone—PIM1—GMCSF-mediated signaling events—CISH—malaria	0.00656	0.0828	CbGpPWpGaD
Mitoxantrone—SLC47A2—kidney—malaria	0.00487	0.0541	CbGeAlD
Mitoxantrone—BTK—hematopoietic system—malaria	0.00448	0.0498	CbGeAlD
Mitoxantrone—SLC47A2—digestive system—malaria	0.00413	0.0459	CbGeAlD
Mitoxantrone—PIM1—hematopoietic system—malaria	0.00388	0.0431	CbGeAlD
Mitoxantrone—PIM1—kidney—malaria	0.00318	0.0354	CbGeAlD
Mitoxantrone—BTK—blood—malaria	0.00297	0.033	CbGeAlD
Mitoxantrone—BTK—TSLP Signaling Pathway—CISH—malaria	0.00292	0.0368	CbGpPWpGaD
Mitoxantrone—BTK—bone marrow—malaria	0.00287	0.0319	CbGeAlD
Mitoxantrone—PIM1—digestive system—malaria	0.0027	0.03	CbGeAlD
Mitoxantrone—PIM1—blood—malaria	0.00257	0.0286	CbGeAlD
Mitoxantrone—PIM1—bone marrow—malaria	0.00249	0.0277	CbGeAlD
Mitoxantrone—SLC47A2—brain—malaria	0.00244	0.0271	CbGeAlD
Mitoxantrone—BTK—liver—malaria	0.00232	0.0258	CbGeAlD
Mitoxantrone—BTK—Fc-epsilon receptor I signaling in mast cells—FCGR2B—malaria	0.00224	0.0282	CbGpPWpGaD
Mitoxantrone—SLC47A1—hematopoietic system—malaria	0.00208	0.0231	CbGeAlD
Mitoxantrone—BTK—BCR signaling pathway—FCGR2B—malaria	0.00208	0.0262	CbGpPWpGaD
Mitoxantrone—PIM1—liver—malaria	0.00201	0.0223	CbGeAlD
Mitoxantrone—BTK—brain—malaria	0.00184	0.0205	CbGeAlD
Mitoxantrone—CYP2E1—blood plasma—malaria	0.00178	0.0198	CbGeAlD
Mitoxantrone—SLC47A1—kidney—malaria	0.00171	0.0189	CbGeAlD
Mitoxantrone—PIM1—brain—malaria	0.0016	0.0177	CbGeAlD
Mitoxantrone—CYP1B1—hematopoietic system—malaria	0.00153	0.0169	CbGeAlD
Mitoxantrone—TOP2A—blood—malaria	0.00151	0.0168	CbGeAlD
Mitoxantrone—TOP2A—bone marrow—malaria	0.00146	0.0162	CbGeAlD
Mitoxantrone—SLC47A1—digestive system—malaria	0.00145	0.0161	CbGeAlD
Mitoxantrone—CYP3A4—blood plasma—malaria	0.00143	0.0159	CbGeAlD
Mitoxantrone—SLC47A2—SLC-mediated transmembrane transport—SLC4A1—malaria	0.00142	0.018	CbGpPWpGaD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—TIRAP—malaria	0.00141	0.0178	CbGpPWpGaD
Mitoxantrone—SLC47A1—blood—malaria	0.00138	0.0153	CbGeAlD
Mitoxantrone—BTK—Regulation of actin dynamics for phagocytic cup formation—FCGR2A—malaria	0.00133	0.0168	CbGpPWpGaD
Mitoxantrone—CYP1B1—kidney—malaria	0.00125	0.0139	CbGeAlD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—CISH—malaria	0.00123	0.0155	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—TIRAP—malaria	0.00122	0.0154	CbGpPWpGaD
Mitoxantrone—ABCG2—saliva-secreting gland—malaria	0.00119	0.0132	CbGeAlD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—TIRAP—malaria	0.00115	0.0145	CbGpPWpGaD
Mitoxantrone—BTK—FAS (CD95) signaling pathway—FAS—malaria	0.00109	0.0137	CbGpPWpGaD
Mitoxantrone—SLC47A1—liver—malaria	0.00108	0.012	CbGeAlD
Mitoxantrone—CYP1B1—digestive system—malaria	0.00106	0.0118	CbGeAlD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TIRAP—malaria	0.00103	0.013	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—TIRAP—malaria	0.00102	0.0129	CbGpPWpGaD
Mitoxantrone—ABCB1—blood plasma—malaria	0.00101	0.0112	CbGeAlD
Mitoxantrone—CYP1B1—blood—malaria	0.00101	0.0112	CbGeAlD
Mitoxantrone—BTK—Fcgamma receptor (FCGR) dependent phagocytosis—FCGR2A—malaria	0.001	0.0127	CbGpPWpGaD
Mitoxantrone—CYP2E1—hematopoietic system—malaria	0.000983	0.0109	CbGeAlD
Mitoxantrone—SLC47A1—SLC-mediated transmembrane transport—SLC4A1—malaria	0.000917	0.0116	CbGpPWpGaD
Mitoxantrone—ABCC1—blood—malaria	0.000909	0.0101	CbGeAlD
Mitoxantrone—SLC47A1—brain—malaria	0.000855	0.0095	CbGeAlD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TLR9—malaria	0.000816	0.0103	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—TLR9—malaria	0.000807	0.0102	CbGpPWpGaD
Mitoxantrone—CYP2E1—kidney—malaria	0.000806	0.00895	CbGeAlD
Mitoxantrone—CYP3A4—hematopoietic system—malaria	0.000791	0.00879	CbGeAlD
Mitoxantrone—CYP1B1—liver—malaria	0.00079	0.00878	CbGeAlD
Mitoxantrone—ABCG2—Fluoropyrimidine Activity—DHFR—malaria	0.000757	0.00956	CbGpPWpGaD
Mitoxantrone—ABCG2—blood—malaria	0.000752	0.00836	CbGeAlD
Mitoxantrone—ABCG2—bone marrow—malaria	0.000728	0.00809	CbGeAlD
Mitoxantrone—SLC47A2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000723	0.00913	CbGpPWpGaD
Mitoxantrone—ABCC1—S1P1 pathway—KDR—malaria	0.000718	0.00907	CbGpPWpGaD
Mitoxantrone—ABCC1—liver—malaria	0.000711	0.00789	CbGeAlD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—HPGDS—malaria	0.000688	0.00868	CbGpPWpGaD
Mitoxantrone—CYP2E1—digestive system—malaria	0.000684	0.0076	CbGeAlD
Mitoxantrone—ABCC1—Arachidonic acid metabolism—HPGDS—malaria	0.000665	0.00839	CbGpPWpGaD
Mitoxantrone—CYP2E1—blood—malaria	0.000651	0.00724	CbGeAlD
Mitoxantrone—CYP3A4—kidney—malaria	0.000648	0.0072	CbGeAlD
Mitoxantrone—CYP1B1—Arachidonic acid metabolism—HPGDS—malaria	0.000643	0.00812	CbGpPWpGaD
Mitoxantrone—Abdominal pain—Proguanil—malaria	0.000639	0.00317	CcSEcCtD
Mitoxantrone—Body temperature increased—Proguanil—malaria	0.000639	0.00317	CcSEcCtD
Mitoxantrone—PIM1—C-MYB transcription factor network—CD4—malaria	0.000635	0.00802	CbGpPWpGaD
Mitoxantrone—CYP1B1—brain—malaria	0.000627	0.00696	CbGeAlD
Mitoxantrone—Jaundice—Clindamycin—malaria	0.00061	0.00303	CcSEcCtD
Mitoxantrone—Urinary tract infection—Clindamycin—malaria	0.000609	0.00302	CcSEcCtD
Mitoxantrone—Sinusitis—Dapsone—malaria	0.000607	0.00301	CcSEcCtD
Mitoxantrone—Renal failure—Quinine—malaria	0.000604	0.003	CcSEcCtD
Mitoxantrone—Renal failure—Quinidine—malaria	0.000604	0.003	CcSEcCtD
Mitoxantrone—Jaundice—Quinine—malaria	0.000599	0.00297	CcSEcCtD
Mitoxantrone—Jaundice—Quinidine—malaria	0.000599	0.00297	CcSEcCtD
Mitoxantrone—Pancytopenia—Quinidine barbiturate—malaria	0.00059	0.00293	CcSEcCtD
Mitoxantrone—Pancytopenia—Pentoxifylline—malaria	0.000589	0.00292	CcSEcCtD
Mitoxantrone—Sweating—Quinine—malaria	0.000589	0.00292	CcSEcCtD
Mitoxantrone—Sweating—Quinidine—malaria	0.000589	0.00292	CcSEcCtD
Mitoxantrone—ABCG2—liver—malaria	0.000588	0.00654	CbGeAlD
Mitoxantrone—Leukopenia—Sulfadiazine—malaria	0.000588	0.00292	CcSEcCtD
Mitoxantrone—Agranulocytosis—Clindamycin—malaria	0.000584	0.0029	CcSEcCtD
Mitoxantrone—Neutropenia—Quinidine barbiturate—malaria	0.000581	0.00288	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL12B—malaria	0.000581	0.00733	CbGpPWpGaD
Mitoxantrone—Pharyngitis—Dapsone—malaria	0.000577	0.00286	CcSEcCtD
Mitoxantrone—Agranulocytosis—Quinine—malaria	0.000573	0.00284	CcSEcCtD
Mitoxantrone—Agranulocytosis—Quinidine—malaria	0.000573	0.00284	CcSEcCtD
Mitoxantrone—TOP2A—Retinoblastoma (RB) in Cancer—DHFR—malaria	0.000572	0.00722	CbGpPWpGaD
Mitoxantrone—BTK—IL-5 Signaling Pathway—IL2—malaria	0.00057	0.0072	CbGpPWpGaD
Mitoxantrone—Convulsion—Sulfadiazine—malaria	0.000569	0.00282	CcSEcCtD
Mitoxantrone—ABCC1—brain—malaria	0.000564	0.00626	CbGeAlD
Mitoxantrone—Bradycardia—Quinine—malaria	0.000561	0.00278	CcSEcCtD
Mitoxantrone—Bradycardia—Quinidine—malaria	0.000561	0.00278	CcSEcCtD
Mitoxantrone—ABCB1—hematopoietic system—malaria	0.00056	0.00622	CbGeAlD
Mitoxantrone—Arthralgia—Sulfadiazine—malaria	0.000559	0.00278	CcSEcCtD
Mitoxantrone—Drowsiness—Quinidine barbiturate—malaria	0.000554	0.00275	CcSEcCtD
Mitoxantrone—Haemoglobin—Quinine—malaria	0.000554	0.00275	CcSEcCtD
Mitoxantrone—Haemoglobin—Quinidine—malaria	0.000554	0.00275	CcSEcCtD
Mitoxantrone—Drowsiness—Pentoxifylline—malaria	0.000553	0.00275	CcSEcCtD
Mitoxantrone—Diarrhoea—Proguanil—malaria	0.000553	0.00274	CcSEcCtD
Mitoxantrone—Haemorrhage—Quinine—malaria	0.000551	0.00274	CcSEcCtD
Mitoxantrone—Haemorrhage—Quinidine—malaria	0.000551	0.00274	CcSEcCtD
Mitoxantrone—Hepatitis—Quinidine—malaria	0.000551	0.00274	CcSEcCtD
Mitoxantrone—Hepatitis—Quinine—malaria	0.000551	0.00274	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL12B—malaria	0.000551	0.00696	CbGpPWpGaD
Mitoxantrone—CYP3A4—digestive system—malaria	0.00055	0.00611	CbGeAlD
Mitoxantrone—Renal failure—Quinidine barbiturate—malaria	0.000545	0.0027	CcSEcCtD
Mitoxantrone—Jaundice—Quinidine barbiturate—malaria	0.00054	0.00268	CcSEcCtD
Mitoxantrone—Jaundice—Pentoxifylline—malaria	0.000539	0.00268	CcSEcCtD
Mitoxantrone—Conjunctivitis—Pentoxifylline—malaria	0.000538	0.00267	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Sulfadiazine—malaria	0.000536	0.00266	CcSEcCtD
Mitoxantrone—Sweating—Quinidine barbiturate—malaria	0.000531	0.00264	CcSEcCtD
Mitoxantrone—Sweating—Pentoxifylline—malaria	0.00053	0.00263	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Sulfadiazine—malaria	0.000525	0.0026	CcSEcCtD
Mitoxantrone—CYP3A4—blood—malaria	0.000524	0.00582	CbGeAlD
Mitoxantrone—Agranulocytosis—Quinidine barbiturate—malaria	0.000517	0.00257	CcSEcCtD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—CD36—malaria	0.000514	0.00649	CbGpPWpGaD
Mitoxantrone—Vomiting—Proguanil—malaria	0.000514	0.00255	CcSEcCtD
Mitoxantrone—Anorexia—Sulfadiazine—malaria	0.000511	0.00254	CcSEcCtD
Mitoxantrone—CYP2E1—liver—malaria	0.000509	0.00566	CbGeAlD
Mitoxantrone—Rash—Proguanil—malaria	0.000509	0.00253	CcSEcCtD
Mitoxantrone—Dermatitis—Proguanil—malaria	0.000509	0.00252	CcSEcCtD
Mitoxantrone—Bradycardia—Quinidine barbiturate—malaria	0.000507	0.00251	CcSEcCtD
Mitoxantrone—Headache—Proguanil—malaria	0.000506	0.00251	CcSEcCtD
Mitoxantrone—Erythema—Dapsone—malaria	0.000506	0.00251	CcSEcCtD
Mitoxantrone—Haemoglobin—Quinidine barbiturate—malaria	0.0005	0.00248	CcSEcCtD
Mitoxantrone—Haemoglobin—Pentoxifylline—malaria	0.000499	0.00248	CcSEcCtD
Mitoxantrone—Hepatitis—Quinidine barbiturate—malaria	0.000498	0.00247	CcSEcCtD
Mitoxantrone—Haemorrhage—Quinidine barbiturate—malaria	0.000498	0.00247	CcSEcCtD
Mitoxantrone—Haemorrhage—Pentoxifylline—malaria	0.000497	0.00246	CcSEcCtD
Mitoxantrone—Hepatitis—Pentoxifylline—malaria	0.000497	0.00246	CcSEcCtD
Mitoxantrone—Chills—Quinine—malaria	0.000495	0.00245	CcSEcCtD
Mitoxantrone—Chills—Quinidine—malaria	0.000495	0.00245	CcSEcCtD
Mitoxantrone—Erythema—Clindamycin—malaria	0.000489	0.00243	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Sulfadiazine—malaria	0.000489	0.00242	CcSEcCtD
Mitoxantrone—Erythema—Quinine—malaria	0.00048	0.00238	CcSEcCtD
Mitoxantrone—Erythema—Quinidine—malaria	0.00048	0.00238	CcSEcCtD
Mitoxantrone—Nausea—Proguanil—malaria	0.00048	0.00238	CcSEcCtD
Mitoxantrone—Dysgeusia—Clindamycin—malaria	0.000479	0.00238	CcSEcCtD
Mitoxantrone—Vision blurred—Dapsone—malaria	0.000477	0.00237	CcSEcCtD
Mitoxantrone—Back pain—Clindamycin—malaria	0.000473	0.00235	CcSEcCtD
Mitoxantrone—ABCG2—brain—malaria	0.000467	0.00519	CbGeAlD
Mitoxantrone—Decreased appetite—Sulfadiazine—malaria	0.000466	0.00231	CcSEcCtD
Mitoxantrone—SLC47A1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000466	0.00588	CbGpPWpGaD
Mitoxantrone—ABCB1—kidney—malaria	0.000459	0.0051	CbGeAlD
Mitoxantrone—Vision blurred—Quinidine—malaria	0.000452	0.00224	CcSEcCtD
Mitoxantrone—Vision blurred—Quinine—malaria	0.000452	0.00224	CcSEcCtD
Mitoxantrone—Anaemia—Clindamycin—malaria	0.000452	0.00224	CcSEcCtD
Mitoxantrone—Chills—Quinidine barbiturate—malaria	0.000446	0.00222	CcSEcCtD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—TLR4—malaria	0.000444	0.00561	CbGpPWpGaD
Mitoxantrone—Arrhythmia—Pentoxifylline—malaria	0.000444	0.0022	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—CD36—malaria	0.000444	0.0056	CbGpPWpGaD
Mitoxantrone—Cough—Dapsone—malaria	0.000441	0.00219	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Sulfadiazine—malaria	0.000438	0.00218	CcSEcCtD
Mitoxantrone—Leukopenia—Clindamycin—malaria	0.000438	0.00217	CcSEcCtD
Mitoxantrone—CYP2E1—Vitamin A and Carotenoid Metabolism—SCARB1—malaria	0.000435	0.00549	CbGpPWpGaD
Mitoxantrone—Erythema—Quinidine barbiturate—malaria	0.000433	0.00215	CcSEcCtD
Mitoxantrone—Erythema—Pentoxifylline—malaria	0.000432	0.00215	CcSEcCtD
Mitoxantrone—Leukopenia—Quinine—malaria	0.00043	0.00213	CcSEcCtD
Mitoxantrone—Leukopenia—Quinidine—malaria	0.00043	0.00213	CcSEcCtD
Mitoxantrone—Urticaria—Sulfadiazine—malaria	0.000426	0.00211	CcSEcCtD
Mitoxantrone—Abdominal pain—Sulfadiazine—malaria	0.000424	0.0021	CcSEcCtD
Mitoxantrone—Body temperature increased—Sulfadiazine—malaria	0.000424	0.0021	CcSEcCtD
Mitoxantrone—Dysgeusia—Pentoxifylline—malaria	0.000423	0.0021	CcSEcCtD
Mitoxantrone—Hypertension—Clindamycin—malaria	0.000422	0.0021	CcSEcCtD
Mitoxantrone—Back pain—Pentoxifylline—malaria	0.000418	0.00208	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—CD36—malaria	0.000417	0.00527	CbGpPWpGaD
Mitoxantrone—Convulsion—Quinine—malaria	0.000416	0.00206	CcSEcCtD
Mitoxantrone—Convulsion—Quinidine—malaria	0.000416	0.00206	CcSEcCtD
Mitoxantrone—Discomfort—Clindamycin—malaria	0.000412	0.00204	CcSEcCtD
Mitoxantrone—CYP3A4—liver—malaria	0.00041	0.00455	CbGeAlD
Mitoxantrone—Chest pain—Quinidine—malaria	0.000409	0.00203	CcSEcCtD
Mitoxantrone—Myalgia—Quinine—malaria	0.000409	0.00203	CcSEcCtD
Mitoxantrone—Myalgia—Quinidine—malaria	0.000409	0.00203	CcSEcCtD
Mitoxantrone—Chest pain—Quinine—malaria	0.000409	0.00203	CcSEcCtD
Mitoxantrone—Vision blurred—Quinidine barbiturate—malaria	0.000408	0.00203	CcSEcCtD
Mitoxantrone—Vision blurred—Pentoxifylline—malaria	0.000408	0.00202	CcSEcCtD
Mitoxantrone—CYP2E1—brain—malaria	0.000404	0.00449	CbGeAlD
Mitoxantrone—Tachycardia—Dapsone—malaria	0.000403	0.002	CcSEcCtD
Mitoxantrone—TOP2A—Mitotic G1-G1/S phases—DHFR—malaria	0.000403	0.00508	CbGpPWpGaD
Mitoxantrone—Ill-defined disorder—Pentoxifylline—malaria	0.000401	0.00199	CcSEcCtD
Mitoxantrone—Anaemia—Pentoxifylline—malaria	0.0004	0.00198	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Clindamycin—malaria	0.000399	0.00198	CcSEcCtD
Mitoxantrone—ABCG2—HIF-2-alpha transcription factor network—KDR—malaria	0.000397	0.00501	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—CD36—malaria	0.000396	0.005	CbGpPWpGaD
Mitoxantrone—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—DHFR—malaria	0.000396	0.005	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Sulfadiazine—malaria	0.000395	0.00196	CcSEcCtD
Mitoxantrone—Confusional state—Quinidine—malaria	0.000395	0.00196	CcSEcCtD
Mitoxantrone—Confusional state—Quinine—malaria	0.000395	0.00196	CcSEcCtD
Mitoxantrone—Oedema—Quinidine—malaria	0.000392	0.00194	CcSEcCtD
Mitoxantrone—Oedema—Quinine—malaria	0.000392	0.00194	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Clindamycin—malaria	0.000391	0.00194	CcSEcCtD
Mitoxantrone—Malaise—Pentoxifylline—malaria	0.00039	0.00193	CcSEcCtD
Mitoxantrone—ABCB1—digestive system—malaria	0.000389	0.00433	CbGeAlD
Mitoxantrone—Leukopenia—Quinidine barbiturate—malaria	0.000388	0.00192	CcSEcCtD
Mitoxantrone—Leukopenia—Pentoxifylline—malaria	0.000387	0.00192	CcSEcCtD
Mitoxantrone—Shock—Quinidine—malaria	0.000385	0.00191	CcSEcCtD
Mitoxantrone—Shock—Quinine—malaria	0.000385	0.00191	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Quinidine—malaria	0.000384	0.0019	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Quinine—malaria	0.000384	0.0019	CcSEcCtD
Mitoxantrone—BTK—Activated TLR4 signalling—TLR4—malaria	0.000383	0.00484	CbGpPWpGaD
Mitoxantrone—Tachycardia—Quinine—malaria	0.000382	0.0019	CcSEcCtD
Mitoxantrone—Tachycardia—Quinidine—malaria	0.000382	0.0019	CcSEcCtD
Mitoxantrone—Skin disorder—Quinidine—malaria	0.000381	0.00189	CcSEcCtD
Mitoxantrone—Skin disorder—Quinine—malaria	0.000381	0.00189	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Quinidine—malaria	0.000379	0.00188	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Quinine—malaria	0.000379	0.00188	CcSEcCtD
Mitoxantrone—Convulsion—Quinidine barbiturate—malaria	0.000375	0.00186	CcSEcCtD
Mitoxantrone—Convulsion—Pentoxifylline—malaria	0.000375	0.00186	CcSEcCtD
Mitoxantrone—Anorexia—Quinidine—malaria	0.000373	0.00185	CcSEcCtD
Mitoxantrone—Anorexia—Quinine—malaria	0.000373	0.00185	CcSEcCtD
Mitoxantrone—Hypertension—Pentoxifylline—malaria	0.000373	0.00185	CcSEcCtD
Mitoxantrone—Hypotension—Clindamycin—malaria	0.000373	0.00185	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—CD36—malaria	0.000372	0.00469	CbGpPWpGaD
Mitoxantrone—ABCB1—blood—malaria	0.000371	0.00412	CbGeAlD
Mitoxantrone—Arthralgia—Quinidine barbiturate—malaria	0.000369	0.00183	CcSEcCtD
Mitoxantrone—Chest pain—Quinidine barbiturate—malaria	0.000369	0.00183	CcSEcCtD
Mitoxantrone—Myalgia—Quinidine barbiturate—malaria	0.000369	0.00183	CcSEcCtD
Mitoxantrone—Myalgia—Pentoxifylline—malaria	0.000368	0.00183	CcSEcCtD
Mitoxantrone—Chest pain—Pentoxifylline—malaria	0.000368	0.00183	CcSEcCtD
Mitoxantrone—Anxiety—Quinidine barbiturate—malaria	0.000368	0.00182	CcSEcCtD
Mitoxantrone—Diarrhoea—Sulfadiazine—malaria	0.000367	0.00182	CcSEcCtD
Mitoxantrone—Anxiety—Pentoxifylline—malaria	0.000367	0.00182	CcSEcCtD
Mitoxantrone—Hypotension—Quinine—malaria	0.000366	0.00182	CcSEcCtD
Mitoxantrone—Hypotension—Quinidine—malaria	0.000366	0.00182	CcSEcCtD
Mitoxantrone—Discomfort—Pentoxifylline—malaria	0.000364	0.0018	CcSEcCtD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—TLR4—malaria	0.000361	0.00455	CbGpPWpGaD
Mitoxantrone—ABCB1—bone marrow—malaria	0.000359	0.00399	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Quinidine—malaria	0.000357	0.00177	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Quinine—malaria	0.000357	0.00177	CcSEcCtD
Mitoxantrone—Confusional state—Quinidine barbiturate—malaria	0.000356	0.00177	CcSEcCtD
Mitoxantrone—BTK—Adaptive Immune System—FCGR2B—malaria	0.000356	0.00449	CbGpPWpGaD
Mitoxantrone—Dyspnoea—Clindamycin—malaria	0.000356	0.00177	CcSEcCtD
Mitoxantrone—Confusional state—Pentoxifylline—malaria	0.000356	0.00177	CcSEcCtD
Mitoxantrone—Oedema—Quinidine barbiturate—malaria	0.000354	0.00175	CcSEcCtD
Mitoxantrone—Anaphylactic shock—Pentoxifylline—malaria	0.000353	0.00175	CcSEcCtD
Mitoxantrone—Oedema—Pentoxifylline—malaria	0.000353	0.00175	CcSEcCtD
Mitoxantrone—Dyspepsia—Clindamycin—malaria	0.000352	0.00174	CcSEcCtD
Mitoxantrone—Infection—Pentoxifylline—malaria	0.000351	0.00174	CcSEcCtD
Mitoxantrone—Dyspnoea—Quinine—malaria	0.000349	0.00173	CcSEcCtD
Mitoxantrone—Dyspnoea—Quinidine—malaria	0.000349	0.00173	CcSEcCtD
Mitoxantrone—Shock—Quinidine barbiturate—malaria	0.000348	0.00173	CcSEcCtD
Mitoxantrone—Shock—Pentoxifylline—malaria	0.000347	0.00172	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Quinidine barbiturate—malaria	0.000346	0.00172	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Pentoxifylline—malaria	0.000346	0.00171	CcSEcCtD
Mitoxantrone—Tachycardia—Quinidine barbiturate—malaria	0.000345	0.00171	CcSEcCtD
Mitoxantrone—Tachycardia—Pentoxifylline—malaria	0.000344	0.00171	CcSEcCtD
Mitoxantrone—Fatigue—Clindamycin—malaria	0.000344	0.00171	CcSEcCtD
Mitoxantrone—Skin disorder—Quinidine barbiturate—malaria	0.000343	0.0017	CcSEcCtD
Mitoxantrone—Skin disorder—Pentoxifylline—malaria	0.000343	0.0017	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Quinidine barbiturate—malaria	0.000342	0.0017	CcSEcCtD
Mitoxantrone—Constipation—Clindamycin—malaria	0.000341	0.00169	CcSEcCtD
Mitoxantrone—Pain—Clindamycin—malaria	0.000341	0.00169	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Pentoxifylline—malaria	0.000341	0.00169	CcSEcCtD
Mitoxantrone—Vomiting—Sulfadiazine—malaria	0.000341	0.00169	CcSEcCtD
Mitoxantrone—Decreased appetite—Quinine—malaria	0.000341	0.00169	CcSEcCtD
Mitoxantrone—Decreased appetite—Quinidine—malaria	0.000341	0.00169	CcSEcCtD
Mitoxantrone—Rash—Sulfadiazine—malaria	0.000338	0.00168	CcSEcCtD
Mitoxantrone—Dermatitis—Sulfadiazine—malaria	0.000338	0.00168	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Dapsone—malaria	0.000338	0.00167	CcSEcCtD
Mitoxantrone—Anorexia—Quinidine barbiturate—malaria	0.000337	0.00167	CcSEcCtD
Mitoxantrone—Anorexia—Pentoxifylline—malaria	0.000336	0.00167	CcSEcCtD
Mitoxantrone—Headache—Sulfadiazine—malaria	0.000336	0.00167	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TIRAP—malaria	0.000331	0.00417	CbGpPWpGaD
Mitoxantrone—Hypotension—Quinidine barbiturate—malaria	0.00033	0.00164	CcSEcCtD
Mitoxantrone—Hypotension—Pentoxifylline—malaria	0.00033	0.00164	CcSEcCtD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000329	0.00415	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Clindamycin—malaria	0.000327	0.00162	CcSEcCtD
Mitoxantrone—Abdominal pain—Dapsone—malaria	0.000326	0.00162	CcSEcCtD
Mitoxantrone—Body temperature increased—Dapsone—malaria	0.000326	0.00162	CcSEcCtD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TLR4—malaria	0.000325	0.0041	CbGpPWpGaD
Mitoxantrone—Feeling abnormal—Quinine—malaria	0.000323	0.0016	CcSEcCtD
Mitoxantrone—Feeling abnormal—Quinidine—malaria	0.000323	0.0016	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Quinidine barbiturate—malaria	0.000322	0.0016	CcSEcCtD
Mitoxantrone—Musculoskeletal discomfort—Pentoxifylline—malaria	0.000322	0.0016	CcSEcCtD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—TLR4—malaria	0.000321	0.00405	CbGpPWpGaD
Mitoxantrone—Gastrointestinal pain—Quinine—malaria	0.00032	0.00159	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Quinidine—malaria	0.00032	0.00159	CcSEcCtD
Mitoxantrone—Nausea—Sulfadiazine—malaria	0.000319	0.00158	CcSEcCtD
Mitoxantrone—Urticaria—Clindamycin—malaria	0.000317	0.00157	CcSEcCtD
Mitoxantrone—BTK—DAP12 interactions—HLA-B—malaria	0.000316	0.00399	CbGpPWpGaD
Mitoxantrone—Abdominal pain—Clindamycin—malaria	0.000316	0.00157	CcSEcCtD
Mitoxantrone—Body temperature increased—Clindamycin—malaria	0.000316	0.00157	CcSEcCtD
Mitoxantrone—Dyspnoea—Quinidine barbiturate—malaria	0.000315	0.00156	CcSEcCtD
Mitoxantrone—Dyspnoea—Pentoxifylline—malaria	0.000315	0.00156	CcSEcCtD
Mitoxantrone—Somnolence—Quinidine barbiturate—malaria	0.000314	0.00156	CcSEcCtD
Mitoxantrone—Somnolence—Pentoxifylline—malaria	0.000314	0.00156	CcSEcCtD
Mitoxantrone—Urticaria—Quinine—malaria	0.000311	0.00154	CcSEcCtD
Mitoxantrone—Urticaria—Quinidine—malaria	0.000311	0.00154	CcSEcCtD
Mitoxantrone—Dyspepsia—Pentoxifylline—malaria	0.000311	0.00154	CcSEcCtD
Mitoxantrone—Abdominal pain—Quinine—malaria	0.00031	0.00154	CcSEcCtD
Mitoxantrone—Abdominal pain—Quinidine—malaria	0.00031	0.00154	CcSEcCtD
Mitoxantrone—Body temperature increased—Quinidine—malaria	0.00031	0.00154	CcSEcCtD
Mitoxantrone—Body temperature increased—Quinine—malaria	0.00031	0.00154	CcSEcCtD
Mitoxantrone—Decreased appetite—Quinidine barbiturate—malaria	0.000307	0.00152	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—CR1—malaria	0.000307	0.00388	CbGpPWpGaD
Mitoxantrone—Decreased appetite—Pentoxifylline—malaria	0.000307	0.00152	CcSEcCtD
Mitoxantrone—Pain—Quinidine barbiturate—malaria	0.000302	0.0015	CcSEcCtD
Mitoxantrone—Constipation—Quinidine barbiturate—malaria	0.000302	0.0015	CcSEcCtD
Mitoxantrone—Constipation—Pentoxifylline—malaria	0.000302	0.0015	CcSEcCtD
Mitoxantrone—BTK—TSLP Signaling Pathway—IL6—malaria	0.000295	0.00372	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Clindamycin—malaria	0.000294	0.00146	CcSEcCtD
Mitoxantrone—Feeling abnormal—Quinidine barbiturate—malaria	0.000291	0.00145	CcSEcCtD
Mitoxantrone—Feeling abnormal—Pentoxifylline—malaria	0.000291	0.00144	CcSEcCtD
Mitoxantrone—ABCB1—liver—malaria	0.00029	0.00322	CbGeAlD
Mitoxantrone—Gastrointestinal pain—Quinidine barbiturate—malaria	0.000289	0.00143	CcSEcCtD
Mitoxantrone—Hypersensitivity—Quinidine—malaria	0.000289	0.00143	CcSEcCtD
Mitoxantrone—Hypersensitivity—Quinine—malaria	0.000289	0.00143	CcSEcCtD
Mitoxantrone—Gastrointestinal pain—Pentoxifylline—malaria	0.000289	0.00143	CcSEcCtD
Mitoxantrone—Asthenia—Clindamycin—malaria	0.000287	0.00142	CcSEcCtD
Mitoxantrone—Asthenia—Quinidine—malaria	0.000281	0.00139	CcSEcCtD
Mitoxantrone—Asthenia—Quinine—malaria	0.000281	0.00139	CcSEcCtD
Mitoxantrone—Urticaria—Quinidine barbiturate—malaria	0.000281	0.00139	CcSEcCtD
Mitoxantrone—Urticaria—Pentoxifylline—malaria	0.00028	0.00139	CcSEcCtD
Mitoxantrone—Body temperature increased—Quinidine barbiturate—malaria	0.000279	0.00139	CcSEcCtD
Mitoxantrone—Abdominal pain—Quinidine barbiturate—malaria	0.000279	0.00139	CcSEcCtD
Mitoxantrone—Abdominal pain—Pentoxifylline—malaria	0.000279	0.00138	CcSEcCtD
Mitoxantrone—Body temperature increased—Pentoxifylline—malaria	0.000279	0.00138	CcSEcCtD
Mitoxantrone—Diarrhoea—Clindamycin—malaria	0.000273	0.00136	CcSEcCtD
Mitoxantrone—CYP2E1—Vitamin A and Carotenoid Metabolism—CD36—malaria	0.000273	0.00345	CbGpPWpGaD
Mitoxantrone—Diarrhoea—Quinidine—malaria	0.000268	0.00133	CcSEcCtD
Mitoxantrone—Diarrhoea—Quinine—malaria	0.000268	0.00133	CcSEcCtD
Mitoxantrone—Vomiting—Dapsone—malaria	0.000262	0.0013	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—TLR9—malaria	0.000261	0.0033	CbGpPWpGaD
Mitoxantrone—Hypersensitivity—Quinidine barbiturate—malaria	0.00026	0.00129	CcSEcCtD
Mitoxantrone—Hypersensitivity—Pentoxifylline—malaria	0.00026	0.00129	CcSEcCtD
Mitoxantrone—Headache—Dapsone—malaria	0.000259	0.00128	CcSEcCtD
Mitoxantrone—Vomiting—Clindamycin—malaria	0.000254	0.00126	CcSEcCtD
Mitoxantrone—Asthenia—Quinidine barbiturate—malaria	0.000254	0.00126	CcSEcCtD
Mitoxantrone—Asthenia—Pentoxifylline—malaria	0.000253	0.00126	CcSEcCtD
Mitoxantrone—Rash—Clindamycin—malaria	0.000252	0.00125	CcSEcCtD
Mitoxantrone—Dermatitis—Clindamycin—malaria	0.000252	0.00125	CcSEcCtD
Mitoxantrone—Headache—Clindamycin—malaria	0.00025	0.00124	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IFNG—malaria	0.00025	0.00315	CbGpPWpGaD
Mitoxantrone—Vomiting—Quinidine—malaria	0.000249	0.00124	CcSEcCtD
Mitoxantrone—Vomiting—Quinine—malaria	0.000249	0.00124	CcSEcCtD
Mitoxantrone—Rash—Quinidine—malaria	0.000247	0.00123	CcSEcCtD
Mitoxantrone—Rash—Quinine—malaria	0.000247	0.00123	CcSEcCtD
Mitoxantrone—Dermatitis—Quinidine—malaria	0.000247	0.00122	CcSEcCtD
Mitoxantrone—Dermatitis—Quinine—malaria	0.000247	0.00122	CcSEcCtD
Mitoxantrone—Headache—Quinidine—malaria	0.000245	0.00122	CcSEcCtD
Mitoxantrone—Headache—Quinine—malaria	0.000245	0.00122	CcSEcCtD
Mitoxantrone—Nausea—Dapsone—malaria	0.000245	0.00122	CcSEcCtD
Mitoxantrone—Diarrhoea—Quinidine barbiturate—malaria	0.000242	0.0012	CcSEcCtD
Mitoxantrone—Diarrhoea—Pentoxifylline—malaria	0.000241	0.0012	CcSEcCtD
Mitoxantrone—CYP1B1—Biological oxidations—HPGDS—malaria	0.000239	0.00302	CbGpPWpGaD
Mitoxantrone—Nausea—Clindamycin—malaria	0.000237	0.00118	CcSEcCtD
Mitoxantrone—Nausea—Quinine—malaria	0.000233	0.00115	CcSEcCtD
Mitoxantrone—Nausea—Quinidine—malaria	0.000233	0.00115	CcSEcCtD
Mitoxantrone—ABCB1—brain—malaria	0.00023	0.00256	CbGeAlD
Mitoxantrone—BTK—Immune System—CISH—malaria	0.000229	0.00289	CbGpPWpGaD
Mitoxantrone—Vomiting—Quinidine barbiturate—malaria	0.000225	0.00112	CcSEcCtD
Mitoxantrone—Vomiting—Pentoxifylline—malaria	0.000224	0.00111	CcSEcCtD
Mitoxantrone—Rash—Quinidine barbiturate—malaria	0.000223	0.00111	CcSEcCtD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL1B—malaria	0.000223	0.00281	CbGpPWpGaD
Mitoxantrone—Dermatitis—Quinidine barbiturate—malaria	0.000223	0.0011	CcSEcCtD
Mitoxantrone—Rash—Pentoxifylline—malaria	0.000223	0.0011	CcSEcCtD
Mitoxantrone—Dermatitis—Pentoxifylline—malaria	0.000222	0.0011	CcSEcCtD
Mitoxantrone—ABCG2—HIF-1-alpha transcription factor network—NOS2—malaria	0.000222	0.0028	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—IL2—malaria	0.000222	0.0028	CbGpPWpGaD
Mitoxantrone—Headache—Quinidine barbiturate—malaria	0.000221	0.0011	CcSEcCtD
Mitoxantrone—Headache—Pentoxifylline—malaria	0.000221	0.0011	CcSEcCtD
Mitoxantrone—BTK—Immune System—FCGR2B—malaria	0.000216	0.00273	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL1B—malaria	0.000211	0.00267	CbGpPWpGaD
Mitoxantrone—Nausea—Quinidine barbiturate—malaria	0.00021	0.00104	CcSEcCtD
Mitoxantrone—Nausea—Pentoxifylline—malaria	0.00021	0.00104	CcSEcCtD
Mitoxantrone—BTK—Innate Immune System—FCGR2A—malaria	0.000209	0.00264	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TIRAP—malaria	0.000193	0.00243	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL12B—malaria	0.000185	0.00234	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—FAS—malaria	0.000182	0.0023	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CR1—malaria	0.000179	0.00226	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC4A1—malaria	0.000175	0.00221	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—FAS—malaria	0.000175	0.00221	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000174	0.00219	CbGpPWpGaD
Mitoxantrone—BTK—MyD88:Mal cascade initiated on plasma membrane—IL6—malaria	0.000169	0.00214	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—DECR1—malaria	0.000168	0.00212	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor Pathway—TNF—malaria	0.000162	0.00204	CbGpPWpGaD
Mitoxantrone—CYP1B1—Aryl Hydrocarbon Receptor—TNF—malaria	0.000162	0.00204	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—HPGDS—malaria	0.000156	0.00197	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC4A1—malaria	0.000154	0.00195	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—TNF—malaria	0.000153	0.00194	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR9—malaria	0.000152	0.00192	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—NOS2—malaria	0.00015	0.00189	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle, Mitotic—DHFR—malaria	0.000148	0.00186	CbGpPWpGaD
Mitoxantrone—BTK—Activated TLR4 signalling—IL6—malaria	0.000146	0.00184	CbGpPWpGaD
Mitoxantrone—BTK—Toll Like Receptor 4 (TLR4) Cascade—IL6—malaria	0.000137	0.00173	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—CD40LG—malaria	0.000136	0.00171	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL10—malaria	0.000136	0.00171	CbGpPWpGaD
Mitoxantrone—TOP2A—Cell Cycle—DHFR—malaria	0.000132	0.00167	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL4—malaria	0.000132	0.00166	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—HLA-B—malaria	0.000129	0.00163	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD40LG—malaria	0.000124	0.00156	CbGpPWpGaD
Mitoxantrone—BTK—Regulation of toll-like receptor signaling pathway—IL6—malaria	0.000124	0.00156	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—HLA-B—malaria	0.000123	0.00155	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD8A—malaria	0.000123	0.00155	CbGpPWpGaD
Mitoxantrone—BTK—Toll-Like Receptors Cascades—IL6—malaria	0.000122	0.00154	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—FCGR2A—malaria	0.000122	0.00154	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—FAS—malaria	0.000122	0.00153	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD36—malaria	0.00012	0.00152	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—NOS2—malaria	0.00012	0.00151	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—HLA-B—malaria	0.000118	0.00149	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD36—malaria	0.000116	0.00146	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CRP—malaria	0.000109	0.00137	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 signaling—IL6—malaria	0.000108	0.00137	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—malaria	0.000108	0.00137	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—TLR4—malaria	0.000104	0.00131	CbGpPWpGaD
Mitoxantrone—BTK—DAP12 interactions—IL6—malaria	0.000102	0.00129	CbGpPWpGaD
Mitoxantrone—BTK—Fc epsilon receptor (FCERI) signaling—IL6—malaria	0.000102	0.00129	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—DHODH—malaria	9.67e-05	0.00122	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—ICAM1—malaria	9.58e-05	0.00121	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—malaria	9.51e-05	0.0012	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—DHODH—malaria	9.35e-05	0.00118	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—HPGDS—malaria	9.2e-05	0.00116	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.73e-05	0.0011	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—DHODH—malaria	8.51e-05	0.00107	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—SCARB1—malaria	8.44e-05	0.00107	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC4A1—malaria	8.35e-05	0.00105	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC4A1—malaria	8.22e-05	0.00104	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IFNG—malaria	7.97e-05	0.00101	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC4A1—malaria	7.95e-05	0.001	CbGpPWpGaD
Mitoxantrone—TOP2A—Integrated Pancreatic Cancer Pathway—TNF—malaria	7.73e-05	0.000976	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—DECR1—malaria	7.73e-05	0.000975	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL18—malaria	7.55e-05	0.000952	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD40LG—malaria	7.52e-05	0.000949	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—DECR1—malaria	7.47e-05	0.000943	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PKLR—malaria	7.44e-05	0.000939	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD8A—malaria	7.43e-05	0.000938	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—CD4—malaria	7.33e-05	0.000925	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—HPGDS—malaria	7.26e-05	0.000916	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC4A1—malaria	7.23e-05	0.000913	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—HLA-B—malaria	7.15e-05	0.000902	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL1B—malaria	7.11e-05	0.000898	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—IL2—malaria	7.09e-05	0.000894	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—CD4—malaria	7.04e-05	0.000888	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD36—malaria	7.01e-05	0.000885	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HBB—malaria	6.99e-05	0.000882	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—DECR1—malaria	6.8e-05	0.000858	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HBB—malaria	6.76e-05	0.000853	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—G6PD—malaria	6.63e-05	0.000837	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CRP—malaria	6.32e-05	0.000798	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PKLR—malaria	6.23e-05	0.000786	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HBB—malaria	6.15e-05	0.000776	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—DHODH—malaria	6.11e-05	0.000771	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—TLR4—malaria	6.06e-05	0.000765	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PKLR—malaria	6.02e-05	0.00076	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—malaria	6e-05	0.000757	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—malaria	5.99e-05	0.000756	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—ICAM1—malaria	5.81e-05	0.000733	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—G6PD—malaria	5.55e-05	0.000701	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PKLR—malaria	5.48e-05	0.000692	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CD36—malaria	5.48e-05	0.000691	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—G6PD—malaria	5.37e-05	0.000678	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CD36—malaria	5.3e-05	0.000669	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC4A1—malaria	5.19e-05	0.000655	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—TNF—malaria	5.16e-05	0.000651	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—G6PD—malaria	4.89e-05	0.000616	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—DECR1—malaria	4.88e-05	0.000616	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—DHFR—malaria	4.69e-05	0.000592	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DHODH—malaria	4.6e-05	0.00058	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IFNG—malaria	4.42e-05	0.000558	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HBB—malaria	4.42e-05	0.000557	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CD4—malaria	4.27e-05	0.000539	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HPGDS—malaria	4.23e-05	0.000534	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HPGDS—malaria	4.1e-05	0.000517	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—malaria	3.96e-05	0.0005	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL1B—malaria	3.94e-05	0.000498	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PKLR—malaria	3.94e-05	0.000497	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—DHFR—malaria	3.93e-05	0.000496	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL2—malaria	3.93e-05	0.000496	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC4A1—malaria	3.91e-05	0.000493	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SCARB1—malaria	3.89e-05	0.000491	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—DHFR—malaria	3.8e-05	0.000479	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SCARB1—malaria	3.76e-05	0.000474	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HPGDS—malaria	3.73e-05	0.00047	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DECR1—malaria	3.68e-05	0.000464	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—G6PD—malaria	3.51e-05	0.000443	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—DHFR—malaria	3.46e-05	0.000436	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SCARB1—malaria	3.42e-05	0.000432	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HBB—malaria	3.32e-05	0.00042	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PKLR—malaria	2.96e-05	0.000374	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DHODH—malaria	2.83e-05	0.000358	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HPGDS—malaria	2.67e-05	0.000338	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—G6PD—malaria	2.64e-05	0.000333	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malaria	2.55e-05	0.000321	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—DHFR—malaria	2.48e-05	0.000313	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SCARB1—malaria	2.46e-05	0.00031	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CD36—malaria	2.44e-05	0.000308	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC4A1—malaria	2.41e-05	0.000304	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NOS2—malaria	2.39e-05	0.000302	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CD36—malaria	2.36e-05	0.000298	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—malaria	2.31e-05	0.000291	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DECR1—malaria	2.26e-05	0.000286	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CD36—malaria	2.15e-05	0.000271	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HBB—malaria	2.05e-05	0.000258	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HPGDS—malaria	2.01e-05	0.000254	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—DHFR—malaria	1.87e-05	0.000236	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SCARB1—malaria	1.85e-05	0.000233	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PKLR—malaria	1.83e-05	0.00023	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—CD4—malaria	1.77e-05	0.000224	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—G6PD—malaria	1.63e-05	0.000205	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CD36—malaria	1.54e-05	0.000194	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HPGDS—malaria	1.24e-05	0.000157	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CD36—malaria	1.16e-05	0.000146	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—DHFR—malaria	1.15e-05	0.000145	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SCARB1—malaria	1.14e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—malaria	9.59e-06	0.000121	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CD36—malaria	7.15e-06	9.02e-05	CbGpPWpGaD
